25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

AONC (American Oncology Network Inc.) Stock Analysis
Buy, Hold or Sell?

Let's analyze American Oncology Network Inc. together

I guess you are interested in American Oncology Network Inc.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – American Oncology Network Inc.’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – American Oncology Network Inc.’s Price Targets

I'm going to help you getting a better view of American Oncology Network Inc.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about American Oncology Network Inc.

I send you an email if I find something interesting about American Oncology Network Inc..

1. Quick Overview

1.1. Quick analysis of American Oncology Network Inc. (30 sec.)










1.2. What can you expect buying and holding a share of American Oncology Network Inc.? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$3.69
Expected worth in 1 year
$7.19
How sure are you?
60.0%

+ What do you gain per year?

Total Gains per Share
$3.50
Return On Investment
53.8%

For what price can you sell your share?

Current Price per Share
$6.50
Expected price per share
$6.15 - $7
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of American Oncology Network Inc. (5 min.)




Live pricePrice per Share (EOD)
$6.50
Intrinsic Value Per Share
$9.72 - $11.67
Total Value Per Share
$13.42 - $15.36

2.2. Growth of American Oncology Network Inc. (5 min.)




Is American Oncology Network Inc. growing?

Current yearPrevious yearGrowGrow %
How rich?$108m$10.3m$57.6m84.8%

How much money is American Oncology Network Inc. making?

Current yearPrevious yearGrowGrow %
Making money-$1.5m-$1.7m$217.7k14.0%
Net Profit Margin-0.4%-0.5%--

How much money comes from the company's main activities?

2.3. Financial Health of American Oncology Network Inc. (5 min.)




2.4. Comparing to competitors in the Medical Care Facilities industry (5 min.)




  Industry Rankings (Medical Care Facilities)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of American Oncology Network Inc.?

Welcome investor! American Oncology Network Inc.'s management wants to use your money to grow the business. In return you get a share of American Oncology Network Inc..

First you should know what it really means to hold a share of American Oncology Network Inc.. And how you can make/lose money.

Speculation

The Price per Share of American Oncology Network Inc. is $6.5. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of American Oncology Network Inc..
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in American Oncology Network Inc., you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $3.69. Based on the TTM, the Book Value Change Per Share is $0.87 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.32 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of American Oncology Network Inc..

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.040.7%-0.05-0.8%-0.15-2.3%-0.05-0.8%-0.02-0.3%-0.02-0.3%
Usd Book Value Change Per Share1.8428.4%0.8713.4%-0.32-5.0%-0.32-4.9%0.253.8%0.253.8%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share1.8428.4%0.8713.4%-0.32-5.0%-0.32-4.9%0.253.8%0.253.8%
Usd Price Per Share5.06-3.88-8.97-7.56-7.35-7.35-
Price to Earnings Ratio28.11-0.46--26.96--8.85--4.22--4.22-
Price-to-Total Gains Ratio2.74-117.90-7.75-81.49-68.14-68.14-
Price to Book Ratio1.37-1.73--54.12--16.58--13.12--13.12-
Price-to-Total Gains Ratio2.74-117.90-7.75-81.49-68.14-68.14-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share6.5
Number of shares153
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.870.25
Usd Total Gains Per Share0.870.25
Gains per Quarter (153 shares)133.7637.67
Gains per Year (153 shares)535.03150.66
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
105355250151141
20107010600301292
30160515950452443
40214021300603594
50267526650753745
60321032000904896
7037453735010551047
8042804270012051198
9048154805013561349
10053505340015071500

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share2.02.00.050.0%5.07.00.041.7%7.08.00.046.7%7.08.00.046.7%7.08.00.046.7%
Book Value Change Per Share3.01.00.075.0%8.04.00.066.7%9.06.00.060.0%9.06.00.060.0%9.06.00.060.0%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.015.00.0%0.00.015.00.0%0.00.015.00.0%
Total Gains per Share3.01.00.075.0%8.04.00.066.7%9.06.00.060.0%9.06.00.060.0%9.06.00.060.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of American Oncology Network Inc. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--1.8430.874+111%-0.323+118%-0.318+117%0.246+649%0.246+649%
Book Value Per Share--3.6932.325+59%0.353+946%2.927+26%4.257-13%4.257-13%
Current Ratio--1.5291.398+9%0.864+77%1.069+43%2.331-34%2.331-34%
Debt To Asset Ratio--0.7700.844-9%0.882-13%0.655+18%0.536+44%0.536+44%
Debt To Equity Ratio--19.3028.594+125%0.320+5926%2.985+547%2.400+704%2.400+704%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value---141684096.000-185021700.000+31%106245844.500-233%87644510.375-262%121558384.491-217%121558384.491-217%
Eps--0.045-0.053+218%-0.146+425%-0.049+210%-0.022+148%-0.022+148%
Ev To Ebitda Ratio---3.751-8.780+134%-7.306+95%3.130-220%5.565-167%5.565-167%
Ev To Sales Ratio---0.072-0.105+45%0.087-183%0.042-271%0.042-271%0.042-271%
Free Cash Flow Per Share--0.1910.454-58%-0.313+264%0.024+685%0.017+1028%0.017+1028%
Free Cash Flow To Equity Per Share--1.8570.855+117%2.901-36%1.899-2%2.266-18%2.266-18%
Gross Profit Margin--1.0001.0000%4.273-77%2.091-52%1.873-47%1.873-47%
Intrinsic Value_10Y_max--11.672----------
Intrinsic Value_10Y_min--9.723----------
Intrinsic Value_1Y_max--0.253----------
Intrinsic Value_1Y_min--0.248----------
Intrinsic Value_3Y_max--1.459----------
Intrinsic Value_3Y_min--1.379----------
Intrinsic Value_5Y_max--3.507----------
Intrinsic Value_5Y_min--3.195----------
Market Cap190114600.000+22%147996904.000113337550.000+31%262285027.000-44%262098853.792-44%256044623.059-42%256044623.059-42%
Net Profit Margin--0.003-0.004+267%-0.005+303%-0.002+161%-0.001+149%-0.001+149%
Operating Margin--0.008-0.013+258%-0.038+580%-0.015+282%-0.012+246%-0.012+246%
Operating Ratio--0.9831.012-3%0.976+1%0.827+19%0.661+49%0.661+49%
Pb Ratio1.760+22%1.3701.728-21%-54.123+4050%-16.582+1310%-13.117+1057%-13.117+1057%
Pe Ratio36.116+22%28.1150.461+6004%-26.962+196%-8.849+131%-4.215+115%-4.215+115%
Price Per Share6.500+22%5.0603.875+31%8.968-44%7.565-33%7.348-31%7.348-31%
Price To Free Cash Flow Ratio8.487+22%6.6071.737+280%-12.309+286%-118.323+1891%-247.803+3851%-247.803+3851%
Price To Total Gains Ratio3.526+22%2.745117.901-98%7.752-65%81.488-97%68.139-96%68.139-96%
Quick Ratio--1.2551.192+5%12.952-90%4.935-75%4.921-75%4.921-75%
Return On Assets--0.003-0.004+236%-0.023+935%-0.006+322%-0.003+214%-0.003+214%
Return On Equity--0.0700.031+123%-0.050+172%-0.004+106%-0.001+102%-0.001+102%
Total Gains Per Share--1.8430.874+111%-0.323+118%-0.318+117%0.246+649%0.246+649%
Usd Book Value--108007000.00068013750.000+59%10324359.750+946%110910879.583-3%151858638.800-29%151858638.800-29%
Usd Book Value Change Per Share--1.8430.874+111%-0.323+118%-0.318+117%0.246+649%0.246+649%
Usd Book Value Per Share--3.6932.325+59%0.353+946%2.927+26%4.257-13%4.257-13%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value---141684096.000-185021700.000+31%106245844.500-233%87644510.375-262%121558384.491-217%121558384.491-217%
Usd Eps--0.045-0.053+218%-0.146+425%-0.049+210%-0.022+148%-0.022+148%
Usd Free Cash Flow--5600000.00013269750.000-58%-9157155.250+264%433223.417+1193%269864.800+1975%269864.800+1975%
Usd Free Cash Flow Per Share--0.1910.454-58%-0.313+264%0.024+685%0.017+1028%0.017+1028%
Usd Free Cash Flow To Equity Per Share--1.8570.855+117%2.901-36%1.899-2%2.266-18%2.266-18%
Usd Market Cap190114600.000+22%147996904.000113337550.000+31%262285027.000-44%262098853.792-44%256044623.059-42%256044623.059-42%
Usd Price Per Share6.500+22%5.0603.875+31%8.968-44%7.565-33%7.348-31%7.348-31%
Usd Profit--1316000.000-1551000.000+218%-1768740.250+234%-158375.667+112%470728.600+180%470728.600+180%
Usd Revenue--490884000.000439871000.000+12%319796250.000+53%303032583.333+62%242426066.667+102%242426066.667+102%
Usd Total Gains Per Share--1.8430.874+111%-0.323+118%-0.318+117%0.246+649%0.246+649%
 EOD+4 -4MRQTTM+29 -8YOY+22 -163Y+19 -195Y+16 -2210Y+16 -22

3.3 Fundamental Score

Let's check the fundamental score of American Oncology Network Inc. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1536.116
Price to Book Ratio (EOD)Between0-11.760
Net Profit Margin (MRQ)Greater than00.003
Operating Margin (MRQ)Greater than00.008
Quick Ratio (MRQ)Greater than11.255
Current Ratio (MRQ)Greater than11.529
Debt to Asset Ratio (MRQ)Less than10.770
Debt to Equity Ratio (MRQ)Less than119.302
Return on Equity (MRQ)Greater than0.150.070
Return on Assets (MRQ)Greater than0.050.003
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of American Oncology Network Inc. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5063.733
Ma 20Greater thanMa 505.392
Ma 50Greater thanMa 1005.248
Ma 100Greater thanMa 2005.103
OpenGreater thanClose6.500
Total4/5 (80.0%)

4. In-depth Analysis

4.1 About American Oncology Network Inc.

American Oncology Network, Inc., through its subsidiaries, provides oncology management services in the United States. The company provides various services to patients, including laboratory services for routine and specialized testing; in-house professional and technical pathology services with pathology reports; in-house specialty pharmacy services with patient education, financial assistance, and 24/7 patient assistance; and care management support services, including nutrition guidance. The company was incorporated in 2017 and is based in Fort Myers, Florida.

Fundamental data was last updated by Penke on 2025-04-27 14:21:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is not making a profit/loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is cheap.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ American Oncology Network Inc. earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ American Oncology Network Inc. to theΒ Medical Care Facilities industry mean.
  • A Net Profit Margin of 0.3%Β means thatΒ $0.00 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of American Oncology Network Inc.:

  • The MRQ is 0.3%. The company is not making a profit/loss.
  • The TTM is -0.4%. The company is not making a profit/loss.
Trends
Current periodCompared to+/- 
MRQ0.3%TTM-0.4%+0.7%
TTM-0.4%YOY-0.5%+0.1%
TTM-0.4%5Y-0.1%-0.3%
5Y-0.1%10Y-0.1%0.0%
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3%4.3%-4.0%
TTM-0.4%4.2%-4.6%
YOY-0.5%2.6%-3.1%
3Y-0.2%3.1%-3.3%
5Y-0.1%3.3%-3.4%
10Y-0.1%3.7%-3.8%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ American Oncology Network Inc. is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ American Oncology Network Inc. to theΒ Medical Care Facilities industry mean.
  • 0.3% Return on Assets means thatΒ American Oncology Network Inc. generatedΒ $0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of American Oncology Network Inc.:

  • The MRQ is 0.3%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is -0.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ0.3%TTM-0.4%+0.7%
TTM-0.4%YOY-2.3%+2.0%
TTM-0.4%5Y-0.3%-0.1%
5Y-0.3%10Y-0.3%0.0%
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3%1.4%-1.1%
TTM-0.4%1.4%-1.8%
YOY-2.3%0.8%-3.1%
3Y-0.6%1.2%-1.8%
5Y-0.3%1.2%-1.5%
10Y-0.3%1.3%-1.6%
4.3.1.3. Return on Equity

Shows how efficient American Oncology Network Inc. is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ American Oncology Network Inc. to theΒ Medical Care Facilities industry mean.
  • 7.0% Return on Equity means American Oncology Network Inc. generated $0.07Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of American Oncology Network Inc.:

  • The MRQ is 7.0%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 3.1%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ7.0%TTM3.1%+3.9%
TTM3.1%YOY-5.0%+8.2%
TTM3.1%5Y-0.1%+3.3%
5Y-0.1%10Y-0.1%0.0%
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ7.0%3.0%+4.0%
TTM3.1%3.2%-0.1%
YOY-5.0%2.4%-7.4%
3Y-0.4%2.6%-3.0%
5Y-0.1%2.4%-2.5%
10Y-0.1%2.9%-3.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of American Oncology Network Inc..

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient American Oncology Network Inc. is operatingΒ .

  • Measures how much profit American Oncology Network Inc. makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ American Oncology Network Inc. to theΒ Medical Care Facilities industry mean.
  • An Operating Margin of 0.8%Β means the company generated $0.01 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of American Oncology Network Inc.:

  • The MRQ is 0.8%. The company is operating inefficient. -1
  • The TTM is -1.3%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ0.8%TTM-1.3%+2.1%
TTM-1.3%YOY-3.8%+2.6%
TTM-1.3%5Y-1.2%-0.1%
5Y-1.2%10Y-1.2%0.0%
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8%6.3%-5.5%
TTM-1.3%7.0%-8.3%
YOY-3.8%6.8%-10.6%
3Y-1.5%6.3%-7.8%
5Y-1.2%7.0%-8.2%
10Y-1.2%7.8%-9.0%
4.3.2.2. Operating Ratio

Measures how efficient American Oncology Network Inc. is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Medical Care Facilities industry mean).
  • An Operation Ratio of 0.98 means that the operating costs are $0.98 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of American Oncology Network Inc.:

  • The MRQ is 0.983. The company is less efficient in keeping operating costs low.
  • The TTM is 1.012. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ0.983TTM1.012-0.029
TTM1.012YOY0.976+0.037
TTM1.0125Y0.661+0.351
5Y0.66110Y0.6610.000
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9831.041-0.058
TTM1.0121.041-0.029
YOY0.9760.982-0.006
3Y0.8271.022-0.195
5Y0.6610.980-0.319
10Y0.6610.968-0.307
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of American Oncology Network Inc..

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if American Oncology Network Inc. is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Medical Care Facilities industry mean).
  • A Current Ratio of 1.53Β means the company has $1.53 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of American Oncology Network Inc.:

  • The MRQ is 1.529. The company is able to pay all its short-term debts. +1
  • The TTM is 1.398. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.529TTM1.398+0.130
TTM1.398YOY0.864+0.535
TTM1.3985Y2.331-0.932
5Y2.33110Y2.3310.000
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5291.238+0.291
TTM1.3981.284+0.114
YOY0.8641.320-0.456
3Y1.0691.362-0.293
5Y2.3311.421+0.910
10Y2.3311.497+0.834
4.4.3.2. Quick Ratio

Measures if American Oncology Network Inc. is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ American Oncology Network Inc. to theΒ Medical Care Facilities industry mean.
  • A Quick Ratio of 1.25Β means the company can pay off $1.25 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of American Oncology Network Inc.:

  • The MRQ is 1.255. The company is able to pay all its short-term debts with the most liquid assets. +1
  • The TTM is 1.192. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ1.255TTM1.192+0.063
TTM1.192YOY12.952-11.761
TTM1.1925Y4.921-3.729
5Y4.92110Y4.9210.000
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2550.652+0.603
TTM1.1920.759+0.433
YOY12.9521.001+11.951
3Y4.9350.961+3.974
5Y4.9211.104+3.817
10Y4.9211.170+3.751
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of American Oncology Network Inc..

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of American Oncology Network Inc.Β assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ American Oncology Network Inc. to Medical Care Facilities industry mean.
  • A Debt to Asset Ratio of 0.77Β means that American Oncology Network Inc. assets areΒ financed with 77.0% credit (debt) and the remaining percentage (100% - 77.0%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of American Oncology Network Inc.:

  • The MRQ is 0.770. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.844. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.770TTM0.844-0.073
TTM0.844YOY0.882-0.038
TTM0.8445Y0.536+0.308
5Y0.53610Y0.5360.000
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7700.497+0.273
TTM0.8440.492+0.352
YOY0.8820.489+0.393
3Y0.6550.492+0.163
5Y0.5360.505+0.031
10Y0.5360.511+0.025
4.5.4.2. Debt to Equity Ratio

Measures ifΒ American Oncology Network Inc. is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ American Oncology Network Inc. to theΒ Medical Care Facilities industry mean.
  • A Debt to Equity ratio of 1,930.2% means that company has $19.30 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of American Oncology Network Inc.:

  • The MRQ is 19.302. The company is unable to pay all its debts with equity. -1
  • The TTM is 8.594. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ19.302TTM8.594+10.708
TTM8.594YOY0.320+8.274
TTM8.5945Y2.400+6.194
5Y2.40010Y2.4000.000
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ19.3020.950+18.352
TTM8.5940.943+7.651
YOY0.3200.923-0.603
3Y2.9850.967+2.018
5Y2.4001.064+1.336
10Y2.4001.126+1.274
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings American Oncology Network Inc. generates.

  • Above 15 is considered overpriced butΒ always compareΒ American Oncology Network Inc. to theΒ Medical Care Facilities industry mean.
  • A PE ratio of 28.11 means the investor is paying $28.11Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of American Oncology Network Inc.:

  • The EOD is 36.116. Based on the earnings, the company is overpriced. -1
  • The MRQ is 28.115. Based on the earnings, the company is overpriced. -1
  • The TTM is 0.461. Based on the earnings, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD36.116MRQ28.115+8.001
MRQ28.115TTM0.461+27.654
TTM0.461YOY-26.962+27.423
TTM0.4615Y-4.215+4.676
5Y-4.21510Y-4.2150.000
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
EOD36.11612.983+23.133
MRQ28.11513.138+14.977
TTM0.46113.601-13.140
YOY-26.96214.647-41.609
3Y-8.84915.549-24.398
5Y-4.21516.947-21.162
10Y-4.21521.375-25.590
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of American Oncology Network Inc.:

  • The EOD is 8.487. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 6.607. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 1.737. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD8.487MRQ6.607+1.880
MRQ6.607TTM1.737+4.870
TTM1.737YOY-12.309+14.046
TTM1.7375Y-247.803+249.540
5Y-247.80310Y-247.8030.000
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
EOD8.4878.266+0.221
MRQ6.6078.757-2.150
TTM1.7378.478-6.741
YOY-12.3097.440-19.749
3Y-118.3238.429-126.752
5Y-247.8037.064-254.867
10Y-247.8037.352-255.155
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ American Oncology Network Inc. is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Medical Care Facilities industry mean).
  • A PB ratio of 1.37 means the investor is paying $1.37Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of American Oncology Network Inc.:

  • The EOD is 1.760. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.370. Based on the equity, the company is underpriced. +1
  • The TTM is 1.728. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.760MRQ1.370+0.390
MRQ1.370TTM1.728-0.358
TTM1.728YOY-54.123+55.850
TTM1.7285Y-13.117+14.845
5Y-13.11710Y-13.1170.000
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
EOD1.7601.621+0.139
MRQ1.3701.717-0.347
TTM1.7281.887-0.159
YOY-54.1232.090-56.213
3Y-16.5822.166-18.748
5Y-13.1172.332-15.449
10Y-13.1172.627-15.744
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of American Oncology Network Inc..

4.8.3. Insider Transactions

Insiders are holding 77.987% of the shares of American Oncology Network Inc..

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-05-24Stephen DiversBUY50002.15
2024-05-21Todd SchonherzBUY53401.87
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2023-12-312024-03-312024-06-302024-09-302024-12-31
Income before Tax  -22,276160-22,11618,846-3,2701,710-1,5603,8932,333
Minority Interest  18,603-1,48317,120-10,3746,746-6,538208-1,297-1,089
Net Income from Continuing Operations  -22,353-2,608-24,96121,836-3,1251,848-1,2773,6822,405



5.2. Latest Balance Sheet

Balance Sheet of 2024-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets470,328
Total Liabilities362,321
Total Stockholder Equity18,771
 As reported
Total Liabilities 362,321
Total Stockholder Equity+ 18,771
Total Assets = 470,328

Assets

Total Assets470,328
Total Current Assets331,472
Long-term Assets138,856
Total Current Assets
Cash And Cash Equivalents 62,849
Short-term Investments 9,791
Net Receivables 189,626
Inventory 60,712
Other Current Assets 8,494
Total Current Assets  (as reported)331,472
Total Current Assets  (calculated)331,472
+/-0
Long-term Assets
Property Plant Equipment 98,531
Goodwill 10,900
Intangible Assets 2,476
Long-term Assets Other 26,949
Long-term Assets  (as reported)138,856
Long-term Assets  (calculated)138,856
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities216,847
Long-term Liabilities145,474
Total Stockholder Equity18,771
Total Current Liabilities
Short-term Debt 12,226
Short Long Term Debt 3,744
Accounts payable 170,736
Other Current Liabilities 33,151
Total Current Liabilities  (as reported)216,847
Total Current Liabilities  (calculated)219,857
+/- 3,010
Long-term Liabilities
Long term Debt 87,123
Capital Lease Obligations Min Short Term Debt44,274
Long-term Liabilities Other 10,333
Long-term Liabilities  (as reported)145,474
Long-term Liabilities  (calculated)141,730
+/- 3,744
Total Stockholder Equity
Common Stock4
Accumulated Other Comprehensive Income 28
Other Stockholders Equity 55,924
Total Stockholder Equity (as reported)18,771
Total Stockholder Equity (calculated)55,956
+/- 37,185
Other
Capital Stock64,990
Cash and Short Term Investments 72,640
Common Stock Shares Outstanding 13,491
Liabilities and Stockholders Equity 470,328
Net Debt 84,518
Net Invested Capital 44,652
Net Working Capital 114,625
Property Plant and Equipment Gross 128,320
Short Long Term Debt Total 147,367



5.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-09-302021-06-302021-03-312020-12-31
> Total Assets 
49
336,751
335,272
335,082
334,598
334,517
335,974
326,228
19,210
19,398
394,014
374,453
421,921
430,762
394,811
470,328
470,328394,811430,762421,921374,453394,01419,39819,210326,228335,974334,517334,598335,082335,272336,75149
   > Total Current Assets 
25
3,251
1,449
1,367
1,070
633
443
242,019
174
94
298,392
277,803
323,963
306,262
271,230
331,472
331,472271,230306,262323,963277,803298,39294174242,0194436331,0701,3671,4493,25125
       Cash And Cash Equivalents 
25
2,313
948
883
581
291
231
26,926
4
2
51,653
28,539
74,944
33,818
19,432
62,849
62,84919,43233,81874,94428,53951,6532426,9262312915818839482,31325
       Short-term Investments 
0
0
0
0
0
0
0
9,851
19,033
0
26,034
35,389
30,105
21,391
0
9,791
9,791021,39130,10535,38926,034019,0339,8510000000
       Net Receivables 
0
0
0
0
0
0
158
166,096
179,380
179,580
179,416
165,029
169,597
188,523
193,144
189,626
189,626193,144188,523169,597165,029179,416179,580179,380166,096158000000
       Other Current Assets 
0
959
501
484
489
342
212
2,670
170
92
3,445
4,277
5,029
8,250
9,388
8,494
8,4949,3888,2505,0294,2773,445921702,6702123424894845019590
   > Long-term Assets 
24
333,500
333,824
333,715
333,528
333,884
335,531
84,209
19,037
19,304
95,622
96,650
97,958
124,500
123,581
138,856
138,856123,581124,50097,95896,65095,62219,30419,03784,209335,531333,884333,528333,715333,824333,50024
       Property Plant Equipment 
0
0
0
0
0
0
0
75,704
77,370
79,111
82,378
83,788
84,355
93,119
91,015
98,531
98,53191,01593,11984,35583,78882,37879,11177,37075,7040000000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
1,050
0
10,900
10,900
10,900
10,90010,90010,90001,05000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
1,754
0
1,327
0
0
001,32701,75400000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
180
0
2,476
2,476
2,476
2,4762,4762,476018000000000000
       Long-term Assets Other 
24
333,500
333,824
203
87
333,884
335,531
7,275
19,037
0
7,055
7,588
12,373
16,678
19,190
26,949
26,94919,19016,67812,3737,5887,055019,0377,275335,531333,88487203333,824333,50024
> Total Liabilities 
25
12,926
25,338
21,893
18,454
16,511
14,562
264,212
20,248
10,895
365,909
368,726
365,813
376,911
340,722
362,321
362,321340,722376,911365,813368,726365,90910,89520,248264,21214,56216,51118,45421,89325,33812,92625
   > Total Current Liabilities 
25
1,253
97
297
990
851
1,868
140,938
7,141
8,644
167,904
169,045
233,829
231,555
199,857
216,847
216,847199,857231,555233,829169,045167,9048,6447,141140,9381,868851990297971,25325
       Short-term Debt 
0
0
0
0
0
0
0
9,602
150
200
7,753
7,881
7,920
12,512
12,388
12,226
12,22612,38812,5127,9207,8817,7532001509,6020000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
3,809
3,809
3,744
3,7443,8093,8090000000000000
       Accounts payable 
0
0
0
0
990
851
1,868
106,495
3,730
122,168
120,383
127,645
188,329
189,483
155,494
170,736
170,736155,494189,483188,329127,645120,383122,1683,730106,4951,8688519900000
       Other Current Liabilities 
25
1,253
97
297
1,028
0
0
24,841
3,780
7,390
35,857
29,848
33,909
28,589
31,004
33,151
33,15131,00428,58933,90929,84835,8577,3903,78024,841001,028297971,25325
   > Long-term Liabilities 
0
11,673
25,241
21,596
17,464
15,660
12,694
123,274
13,106
2,251
198,005
199,681
131,984
145,356
140,865
145,474
145,474140,865145,356131,984199,681198,0052,25113,106123,27412,69415,66017,46421,59625,24111,6730
       Other Liabilities 
0
0
0
0
0
0
0
4,130
6,056
5,957
0
0
0
0
0
0
0000005,9576,0564,1300000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
800
0
0
0
0
0
0
0
000000080000000000
> Total Stockholder Equity
24
323,826
309,934
313,189
316,144
318,006
321,412
-14,204
-1,037
8,503
-341,332
-161,727
-102,460
25,002
-38,840
18,771
18,771-38,84025,002-102,460-161,727-341,3328,503-1,037-14,204321,412318,006316,144313,189309,934323,82624
   Common Stock
1
318,827
304,935
333,501
333,501
333,567
334,926
676,241
18,622
18,672
4
4
4
4
4
4
44444418,67218,622676,241334,926333,567333,501333,501304,935318,8271
   Retained Earnings 
-1
-36
4,999
-20,312
-17,357
-15,561
-13,514
25,828
-19,659
-21,371
-341,357
-161,812
-175,594
-66,720
-103,488
-102,171
-102,171-103,488-66,720-175,594-161,812-341,357-21,371-19,65925,828-13,514-15,561-17,357-20,3124,999-36-1
   Capital Surplus 0000000000000000
   Treasury Stock0000000000000000
   Other Stockholders Equity 
24
5,035
0
0
-668,378
-668,082
-670,898
-716,156
-37,830
11,203
-64,986
-64,986
8,067
26,706
-368
55,924
55,924-36826,7068,067-64,986-64,98611,203-37,830-716,156-670,898-668,082-668,378005,03524



5.4. Balance Sheets

Currency in USD. All numbers in thousands.




5.5. Cash Flows

Currency in USD. All numbers in thousands.




5.6. Income Statements

Currency in USD. All numbers in thousands.


5.7. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue1,759,484
Cost of Revenue-1,641,638
Gross Profit117,846117,846
 
Operating Income (+$)
Gross Profit117,846
Operating Expense-135,275
Operating Income-17,429-17,429
 
Operating Expense (+$)
Research Development0
Selling General Administrative133,937
Selling And Marketing Expenses0
Operating Expense135,275133,937
 
Net Interest Income (+$)
Interest Income3,199
Interest Expense-7,057
Other Finance Cost-0
Net Interest Income-3,858
 
Pretax Income (+$)
Operating Income-17,429
Net Interest Income-3,858
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-7,025-27,833
EBIT - interestExpense = -24,613
-1,475
3,084
Interest Expense7,057
Earnings Before Interest and Taxes (EBIT)-17,55632
Earnings Before Interest and Taxes (EBITDA)-17,429
 
After tax Income (+$)
Income Before Tax-7,025
Tax Provision-2,498
Net Income From Continuing Ops-26,958-9,523
Net Income-3,973
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses1,776,913
Total Other Income/Expenses Net10,4043,858
 

Technical Analysis of American Oncology Network Inc.
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of American Oncology Network Inc.. The general trend of American Oncology Network Inc. is BULLISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine American Oncology Network Inc.'s overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (100.0%) Bearish trend (-100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. American Oncology Network Inc. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of American Oncology Network Inc..

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 6.55 < 6.74 < 7.

The bearish price targets are: 6.3 > 6.3 > 6.15.

Know someone who trades $AONC? Share this with them.πŸ‘‡

American Oncology Network Inc. Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of American Oncology Network Inc.. The current mas is .

The long score for the Moving Averages is 14/14.
The longshort score for the Moving Averages is 14/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

American Oncology Network Inc. Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of American Oncology Network Inc.. The current macd is 0.34398882.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the American Oncology Network Inc. price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for American Oncology Network Inc.. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the American Oncology Network Inc. price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
American Oncology Network Inc. Daily Moving Average Convergence/Divergence (MACD) ChartAmerican Oncology Network Inc. Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of American Oncology Network Inc.. The current adx is 33.58.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy American Oncology Network Inc. shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
American Oncology Network Inc. Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of American Oncology Network Inc.. The current sar is 5.30268667.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
American Oncology Network Inc. Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of American Oncology Network Inc.. The current rsi is 63.73. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
American Oncology Network Inc. Daily Relative Strength Index (RSI) ChartAmerican Oncology Network Inc. Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of American Oncology Network Inc.. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the American Oncology Network Inc. price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
American Oncology Network Inc. Daily Stochastic Oscillator ChartAmerican Oncology Network Inc. Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of American Oncology Network Inc.. The current cci is 134.32.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
American Oncology Network Inc. Daily Commodity Channel Index (CCI) ChartAmerican Oncology Network Inc. Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of American Oncology Network Inc.. The current cmo is 33.57.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
American Oncology Network Inc. Daily Chande Momentum Oscillator (CMO) ChartAmerican Oncology Network Inc. Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of American Oncology Network Inc.. The current willr is -11.26760563.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
American Oncology Network Inc. Daily Williams %R ChartAmerican Oncology Network Inc. Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of American Oncology Network Inc..

American Oncology Network Inc. Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of American Oncology Network Inc.. The current atr is 0.34208066.

American Oncology Network Inc. Daily Average True Range (ATR) ChartAmerican Oncology Network Inc. Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of American Oncology Network Inc.. The current obv is 9,082,181.

American Oncology Network Inc. Daily On-Balance Volume (OBV) ChartAmerican Oncology Network Inc. Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of American Oncology Network Inc.. The current mfi is 57.25.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
American Oncology Network Inc. Daily Money Flow Index (MFI) ChartAmerican Oncology Network Inc. Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for American Oncology Network Inc..

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-12-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-12-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-12-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-12MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-16CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-12-17SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-20CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-12-23WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-12-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-12-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-12-31STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-01-03CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-01-10RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-16CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-01-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-01-24STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-01-29CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-01-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-31STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-03STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-07STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-11STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-12WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-02-13STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-19CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-02-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-24STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-27BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-02-28STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-03-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-03-14CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-17MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-19STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-20CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-25STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-03-27CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-04-03CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-04-07STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-09CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-04-10STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-11CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-04-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-04-16SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-04-17BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-23CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-24STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-25WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-29STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-02STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside

6.3. Candlestick Patterns

American Oncology Network Inc. Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of American Oncology Network Inc. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5063.733
Ma 20Greater thanMa 505.392
Ma 50Greater thanMa 1005.248
Ma 100Greater thanMa 2005.103
OpenGreater thanClose6.500
Total4/5 (80.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of American Oncology Network Inc. with someone you think should read this too:
  • Are you bullish or bearish on American Oncology Network Inc.? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about American Oncology Network Inc.? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about American Oncology Network Inc.

I send you an email if I find something interesting about American Oncology Network Inc..


Comments

How you think about this?

Leave a comment

Stay informed about American Oncology Network Inc..

Receive notifications about American Oncology Network Inc. in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.